GAMMA Investing’s bluebird bio BLUE Stock Holding History

GAMMA Investing’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$146	–	3786
2025 Q1	$146	Buy	30 +11	+58%	+$66	﹤0.01%	3770
2024 Q4	$158	Buy	+19	New	+$166	﹤0.01%	3726

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's BLUE Position: Q2 2025 in Review

GAMMA Investing sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 30 shares — an estimated $146 sold.

GAMMA Investing first reported a position in BLUE in Q4 2024 and held it in 2 quarters. The position peaked at $158 in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

GAMMA Investing reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
GAMMA Investing sold 30 bluebird bio shares in Q2 2025, an estimated $146.
GAMMA Investing first reported a position in bluebird bio in Q4 2024 and held it in 2 quarters.
GAMMA Investing's bluebird bio position peaked at $158 in Q4 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.